Details

NameSymbolSector
GENOMIC VALLEY BIOTECH LIMITEDGVBLBiotechnology
Open
34.3
High
34.3
Low
34.3
Close
34.3
Volume
737
Exchange
bse
Time
16-Oct-2026

Outlook

Score:  

0

Rating:  

RISKY

Candlestick Pattern

Candle pattern of Genomic Valley Biotech is  
Doji
Estimated Stoploss of Genomic Valley Biotech is ₹  
34.3
Genomic Valley Biotech has a  
Bearishℹ
 pattern. 
Formation of  
Doji
 candle pattern indicates the trend direction of Genomic Valley Biotech is  
Unpredictableℹ
. 

Trend

Genomic Valley Biotech is in  
Sideways trendℹ
. 
Price of Genomic Valley Biotech is  
Upℹ
 by  

13.31

%. 
Target
Buy @ 

26.67

Sell @ 

33.21

Current @ 

34.3

Volume

The trade volumes of Genomic Valley Biotech have been  
Underperformingℹ
Though the volume trend for Genomic Valley Biotech appears  
Bullishℹ
 the participants seem to be  
Weak Buyersℹ
The trade volume of Genomic Valley Biotech is  

Down

 by  

5.36

% 

Valuation

The current market price of Genomic Valley Biotech is  
Overvaluedℹ

Financials

Balance
With total liablities and shareholder equity worth ₹ 4cr and total assets worth ₹ 4cr, the balance sheet of Genomic Valley Biotech is:  
Balancedℹ
. 
Cashflow
The cashflow data is not available! 

Income
The income of Genomic Valley Biotech is  

₹ 0cr

 and  

Loss

 is :  

₹ 0cr

(*Sep 2025)

Genomic Valley Biotech Losses increased by:  

0

% and Income is Up by:  

0

% 

(*Sep 2025)

The income of Genomic Valley Biotech is  

₹ 0cr

 and  

Loss

 is :  

₹ 0cr

(*Jun 2025)

Genomic Valley Biotech Losses increased by:  

0

% and Income is Up by:  

0

% 

(*Jun 2025)

The income of Genomic Valley Biotech is  

₹ 0cr

 and  

Loss

 is :  

₹ 0cr

(*Mar 2025)

Genomic Valley Biotech Losses increased by:  

0

% and Income is Up by:  

0

% 

(*Mar 2025)

Market Cap

Market capital of GENOMIC VALLEY BIOTECH LIMITED is 7cr

Top Rated Competitors

NameScore
Advanced Enzyme Technologies Limited
3.25
Shree Ganesh Biotech (India) Limited
1.75
GENESIS IBRC INDIA LIMITED
1
Vivo Bio tech Ltd.
0
By using this site you agree to the use of cookies to deliver a better site experience.